Nitric oxide-sensitive guanylyl cyclase: Structure and regulation

Neurochemistry International

Volumn 45, Issue 6, 2004, Pages 813-819

  Koesling, Doris ^a   Russwurm, Michael ^a   Mergia, Evanthia ^a   Mullershausen, Florian ^a   Friebe, Andreas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

3 (5 hydroxymethyl 2 furyl) 1 benzylindazole; cGMP; GC; guanylyl cyclase; Nitric oxide; nitric oxide; NO; NO sensitive guanylyl cyclase; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 6 ANILINO 5,8 QUINOLINEQUINONE; BENZENE DERIVATIVE; CARBON MONOXIDE; CYTOCHROME C; GUANYLATE CYCLASE; HEME; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NS 2028; OXADIAZOLO[3,4 D]BENZ[1,4]OXAZIN 1 ONE; PDZ PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BETA CHAIN; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CYTOSOL; DIMERIZATION; DISSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; HALF LIFE TIME; HUMAN; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SENSOR; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; ENZYME ACTIVATION; GUANYLATE CYCLASE; HUMANS; ISOENZYMES; NITRIC OXIDE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TISSUE DISTRIBUTION;

EID: 4243049145     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2004.03.011     Document Type: Conference Paper

References (76)

1. + currents in frog cardiac myocytes. Br. J. Pharmacol. 121:1997;1369-1377
2. 2 subunit of soluble guanylyl cyclase contains a human-specific frameshift and is expressed in gastric carcinoma. Biochem. Biophys. Res. Commun. 271:2000;64-69
3. Bellamy T.C., Wood J., Goodwin D.A., Garthwaite J. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl. Acad. Sci.: USA. 97:2000;2928-2933
4. Bellamy T.C., Garthwaite J. Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells. J. Biol. Chem. 276:2001;4287-4292
5. Brandish P.E., Buechler W., Marletta M.A. Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin. Biochemistry. 37:1998;16898-16907
6. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770
7. 1-syntrophin mediated by PDZ domains. Cell. 84:1996;757-767
8. Brunner F., Schmidt K., Nielsen E.B., Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J. Pharmacol. Exp. Ther. 277:1996;48-53
9. Budworth J., Meillerais S., Charles I., Powell K. Tissue distribution of the human soluble guanylate cyclases. Biochem. Biophys. Res. Commun. 263:1999;696-701
10. Burette A., Zabel U., Weinberg R.J., Schmidt H.H., Valtschanoff J.G. Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J. Neurosci. 22:2002;8961-8970
11. Cho K.O., Hunt C.A., Kennedy M.B. The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron. 9:1992;929-942
12. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 274:1999;27467-27473
13. Craven S.E., Bredt D.S. PDZ proteins organize synaptic signaling pathways. Cell. 93:1998;495-498
14. Denninger J.W., Schelvis J.P., Brandish P.E., Zhao Y., Babcock G.T., Marletta M.A. Interaction of soluble guanylate cyclase with YC-1: kinetic and resonance Raman studies. Biochemistry. 39:2000;4191-4198
15. 1 subunits. Eur. J. Biochem. 240:1996;380-386
16. Friebe A., Schultz G., Koesling D. Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J. 15:1996;6863-6868
17. Friebe A., Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol. 53:1998;123-127
18. Friebe A., Mullershausen F., Smolenski A., Walter U., Schultz G., Koesling D. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol. Pharmacol. 54:1998;962-967
19. Friebe A., Russwurm M., Mergia E., Koesling D. A point-mutated guanylyl cyclase with features of the YC-1-stimulated enzyme: implications for the YC-1 binding site? Biochemistry. 38:1999;15253-15257
20. 1 subunits of soluble guanylate cyclase in the rat brain. Brain. Res. Mol. Brain. Res. 20:1993;335-344
21. Galle J., Zabel U., Hubner U., Hatzelmann A., Wagner B., Wanner C., Schmidt H.H. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br. J. Pharmacol. 127:1999;195-203
22. Garner C.C., Nash J., Huganir R.L. PDZ domains in synapse assembly and signalling. Trends Cell. Biol. 10:2000;274-280
23. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388
24. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188
25. Gerzer R., Böhme E., Hofmann F., Schultz G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett. 132:1981;71-74
26. Gibb B.J., Garthwaite J. Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. Eur. J. Neurosci. 13:2001;539-544
27. Hardman J.G., Sutherland E.W. Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine trihosphate. J. Biol. Chem. 244:1969;6363-6370
28. Harteneck C., Wedel B., Koesling D., Malkewitz J., Böhme E., Schultz G. Molecular cloning and expression of a new α-subunit of soluble guanylyl cyclase. Interchangeability of the α-subunits of the enzyme. FEBS Lett. 292:1991;217-222
29. Humbert P., Niroomand F., Fischer G., Mayer B., Koesling D., Hinsch K.D., Gausepohl H., Frank R., Schultz G., Böhme E. Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur. J. Biochem. 190:1990;273-278
30. Ignarro L.J., Wood K.S., Wolin M.S. Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proc. Natl. Acad. Sci.: USA. 79:1982;2870-2873
31. Kharitonov V.G., Sharma V.S., Magde D., Koesling D. Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase. Biochemistry. 36:1997a;6814-6818
32. Kharitonov V.G., Russwurm M., Magde D., Sharma V.S., Koesling D. Dissociation of nitric oxide from soluble guanylate cyclase. Biochem. Biophys. Res. Commun. 239:1997b;284-286
33. Kiedrowski L., Costa E., Wroblewski J.T. Glutamate receptor agonists stimulate nitric oxide synthase in primary cultures of cerebellar granule cells. J. Neurochem. 58:1992;335-341
34. Koesling D., Herz J., Gausepohl H., Niroomand F., Hinsch K.D., Mülsch A., Böhme E., Schultz G., Frank R. The primary structure of the 70 kDa subunit of bovine soluble guanylate cyclase. FEBS Lett. 239:1988;29-34
35. Koesling D., Harteneck C., Humbert P., Bosserhoff A., Frank R., Schultz G., Böhme E. The primary structure of the larger subunit of soluble guanylyl cyclase from bovine lung. Homology between the two subunits of the enzyme. FEBS Lett. 266:1990;128-132
36. 1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding. J. Biol. Chem. 278:2003;12590-12597
37. Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science. 269:1995;1737-1740
38. Lawson D.M., Stevenson C.E., Andrew C.R., George S.J., Eady R.R. A two-faced molecule offers NO explanation: the proximal binding of nitric oxide to haem. Biochem. Soc. Trans. 31:2003;553-557
39. Leinders-Zufall T., Zufall F. Block of cyclic nucleotide-gated channels in salamander olfactory receptor neurons by the guanylyl cyclase inhibitor LY83583. J. Neurophysiol. 74:1995;2759-2762
40. Margulis A., Sitaramayya A. Rate of deactivation of nitric oxide-stimulated soluble guanylate cyclase: influence of nitric oxide scavengers and calcium. Biochemistry. 39:2000;1034-1039
41. Mayer B., Brunner F., Schmidt K. Novel actions of methylene blue. Eur. Heart J. 14:1993;22-26
42. 1 isoform of NO-sensitive guanylyl cyclase in brain. Cell. Signal. 15:2003;189-195
43. Moro M.A., Russel R.J., Cellek S., Lizasoain I., Su Y., Darley-Usmar V.M., Radomski M.W., Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci.: USA. 93:1996;1480-1485
44. Müller B.M., Kistner U., Veh R.W., Cases-Langhoff C., Becker B., Gundelfinger E.D., Garner C.C. Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J. Neurosci. 15:1995;2354-2366
45. Nakane M., Saheki S., Kuno T., Ishii K., Murad F. Molecular cloning of acDNA coding for 70 kDa subunit of soluble guanylate cyclase from rat lung. Biochem. Biophys. Res. Commun. 157:1988;1139-1147
46. Nakane M., Arai K., Saheki S., Kuno T., Buechler W., Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J. Biol. Chem. 265:1990;16841-16845
47. Nedvetsky P.I., Sessa W.C., Schmidt H.H. There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling. Proc. Natl. Acad. Sci.: USA. 99:2002;16510-16512
48. Niethammer M., Kim E., Sheng M. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J. Neurosci. 16:1996;2157-2163
49. Olesen S.P., Drejer J., Axelsson O., Moldt P., Bang L., Nielsen-Kudsk J.E., Busse R., Mülsch A. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br. J. Pharmacol. 123:1998;299-309
50. Russwurm M., Behrends S., Harteneck C., Koesling D. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem. J. 335:1998;125-130
51. 1 guanylyl cyclase to synaptic membranes. J. Biol. Chem. 276:2001;44647-44652
52. Russwurm M., Mergia E., Mullershausen F., Koesling D. Inhibition of deactivation of NO-sensitive guanylyl cyclase accounts for the sensitizing effect of YC-1. J. Biol. Chem. 277:2002;24883-24888
53. Schelvis J.P., Zhao Y., Marletta M.A., Babcock G.T. Resonance raman characterization of the heme domain of soluble guanylate cyclase. Biochemistry. 37:1998;16289-16297
54. Schrammel A., Behrends S., Schmidt K., Koesling D., Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 50:1996;1-5
55. Sharma V.S., Magde D. Activation of soluble guanylate cyclase by carbon monoxide and nitric oxide: a mechanistic model. Methods. 19:1999;494-505
56. Sheng M., Pak D.T. Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Ann. Rev. Physiol. 62:2000;755-778
57. Stasch J.P., Becker E.M., Alonso-Alija C., Apeler H., Dembowsky K., Feurer A., Gerzer R., Minuth T., Perzborn E., Pleiss U., Schroder H., Schroeder W., Stahl E., Steinke W., Straub A., Schramm M. NO-independent regulatory site on soluble guanylate cyclase. Nature. 410:2001;212-215
58. Stasch J.P., Alonso-Alija C., Apeler H., Dembowsky K., Feurer A., Minuth T., Perzborn E., Schramm M., Straub A. Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies. Br. J. Pharmacol. 135:2002a;333-343
59. Stasch J.P., Schmidt P., Alonso-Alija C., Apeler H., Dembowsky K., Haerter M., Heil M., Minuth T., Perzborn E., Pleiss U., Schramm M., Schroeder W., Schroder H., Stahl E., Steinke W., Wunder F. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br. J. Pharmacol. 136:2002b;773-783
60. Stone J.R., Marletta M.A. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry. 33:1994;5636-5640
61. Stone J.R., Marletta M.A. Heme stoichiometry of heterodimeric soluble guanylate cyclase. Biochemistry. 34:1995;14668-14674
62. Sunahara R.K., Beuve A., Tesmer J.J., Sprang S.R., Garbers D.L., Gilman A.G. Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases. J. Biol. Chem. 273:1998;16332-16338
63. sα GTPγS. Science. 278:1997;1907-1916
64. Tesmer J.J., Sunahara R.K., Johnson R.A., Gosselin G., Gilman A.G., Sprang S.R. Two-metal-Ion catalysis in adenylyl cyclase. Science. 285:1999;756-760
65. Tucker C.L., Hurley J.H., Miller T.R., Hurley J.B. Two amino acid substitutions convert a guanylyl cyclase, RetGC-1, into an adenylyl cyclase. Proc. Natl. Acad. Sci.: USA. 95:1998;5993-5997
66. 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc. Natl. Acad. Sci.: USA. 91:1994;2592-2596
67. Wedel B., Harteneck C., Foerster J., Friebe A., Schultz G., Koesling D. Functional domains of soluble guanylyl cyclase. J. Biol. Chem. 270:1995;24871-24875
68. Wilson E.M., Chinkers M. Identification of sequences mediating guanylyl cyclase dimerization. Biochemistry. 34:1995;4696-4701
69. Wu C.C., Ko F.N., Kuo S.C., Lee F.Y., Teng C.M. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol. 116:1995;1973-1978
70. Yuen P.S., Potter L.R., Garbers D.L. A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry. 29:1990;10872-10878
71. Zabel U., Hausler C., Weeger M., Schmidt H.H. Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione s-transferase affinity tag. J. Biol. Chem. 274:1999;18149-18152
72. Zabel U., Kleinschnitz C., Oh P., Nedvetsky P., Smolenski A., Müller H., Kronich P., Kugler P., Walter U., Schnitzer J.E., Schmidt H.H. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat. Cell. Biol. 4:2002;4
73. Zhang G., Liu Y., Ruoho A.E., Hurley J.H. Structure of the adenylyl cyclase catalytic core. Nature. 386:1997;247-253
74. 1 subunit of soluble guanylate cyclase as the heme proximal ligand. Biochemistry. 37:1998;4502-4509
75. Zhao Y., Brandish P.E., Ballou D.P., Marletta M.A. A molecular basis for nitric oxide sensing by soluble guanylate cyclase. Proc. Natl. Acad. Sci.: USA. 96:1999;14753-14758
76. Zhao Y., Brandish P.E., DiValentin M., Schelvis J.P., Babcock G.T., Marletta M.A. Inhibition of soluble guanylate cyclase by ODQ. Biochemistry. 39:2000;10848-10854